Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2419942
Max Phase: Preclinical
Molecular Formula: C41H42N2O21
Molecular Weight: 898.78
Molecule Type: Small molecule
Associated Items:
ID: ALA2419942
Max Phase: Preclinical
Molecular Formula: C41H42N2O21
Molecular Weight: 898.78
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@H](C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)OCc2ccc(O[C@@H]3O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]3O)c([N+](=O)[O-])c2)[C@H](O)[C@H](C)O1
Standard InChI: InChI=1S/C41H42N2O21/c1-14-30(46)19(42-41(56)60-13-15-6-7-22(20(8-15)43(57)58)63-40-37(53)35(51)36(52)38(64-40)39(54)55)11-25(61-14)62-24-10-16(21(45)12-44)9-18-27(24)34(50)29-28(32(18)48)31(47)17-4-3-5-23(59-2)26(17)33(29)49/h3-8,14,16,19,24-25,30,35-38,40,44,46,48,50-53H,9-13H2,1-2H3,(H,42,56)(H,54,55)/t14-,16+,19-,24-,25-,30+,35-,36-,37+,38-,40+/m0/s1
Standard InChI Key: DKGIHJPWTMZRSU-LQYIKZRDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 898.78 | Molecular Weight (Monoisotopic): 898.2280 | AlogP: 0.03 | #Rotatable Bonds: 12 |
Polar Surface Area: 357.74 | Molecular Species: ACID | HBA: 20 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.70 | CX Basic pKa: | CX LogP: 2.33 | CX LogD: -1.26 |
Aromatic Rings: 3 | Heavy Atoms: 64 | QED Weighted: 0.05 | Np Likeness Score: 1.10 |
1. Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Jayle C, Alsarraf J, Thomas M, Papot S.. (2013) Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy., 67 [PMID:23845743] [10.1016/j.ejmech.2013.06.037] |
Source(1):